The Asian Pacific Association for the Study of the Liver [APASL]

Hepatology International

 Facebook - https://www.facebook.com/hepatologyinternational


 LinkedIn - https://www.linkedin.com/company/hepatology-international/


 Instagram - https://www.instagram.com/hepatologyinternational/


 Twitter - https://twitter.com/hepinternation1

Dear members,
Hepatology International extends its Warmest Greetings !
As we step into yet another year of new targets, renewed expectations and hope, with reflections of the successes and limitations of the passing year, we would like to express our sincere thanks and gratitude to all our members who have remained an integral part of the Hepatology International through its journey all these years.
The journal, under the able guidance and leadership of Prof Masao Omata and Prof Shiv Sarin, has come a long way since its inception in 2007, establishing itself in the field of Hepatology and Biliary Sciences, earning a place in PubMed and ISI, and achieving a distinct impact factor of 9.029 for the year 2021 .
We would like to take this opportunity to encourage each one of you to continue to align with us and extend your gracious support and cooperation to the journal in the coming years.
We look forward to a deeply cherished association with you.

With warmest regards,

Prof. Masao Omata Prof. Shiv K. Sarin
EIC Hepatology International EIC Hepatology International

This official journal was launched in 2007 and publishes the abstracts of the Annual Meeting, original and review articles, and APASL guidelines.

  • The journal is issued bimonthly and growing rapidly. We received over 400 manuscript submissions in a year and the acceptance rate of original article is now 10 to 20%.
  • We are delighted to inform you that the Impact Factor of Hepatology International has touched a new high of 6.047 for the year 2020-2021 from 5.102  in the year 2019-2020. 

 

 

Hep-I OFFICIAL Twitter page has opened!

Hepatology International official Twitter page has opened!

You can check it out from the link below. Please follow us!

https://twitter.com/hepinternation1?s=20

You can also check out Hepatology International from here!

 

SharedIt services: A boon for Authors/Researchers

SharedIt is part of Springer Nature initiative that allows authors to share their research to wider communities by enabling over 200 key media outlets and blogs to link to free-to-read versions of research articles. This media list has been significantly expanded to coincide with the expansion of the initiative across the Springer Nature portfolio. Many on this media list are aimed at the public, including BBC, The Economist, WIRED, The New York Times, as well as leading science bloggers.

Upon publication, corresponding authors are emailed a shareable link to view-only versions of their peer-reviewed research papers. All corresponding authors are sent this link, even those with papers published in open access journals. A stable, shortened URL is made available for published authors to share the full-text access to their paper by using the link http://rdcu.be/p2UW

Enhanced PDF: The link takes the author to a read-only enhanced PDF format of their published paper.

For open-access articles, all readers will be able to download, print and save an enhanced PDF, or to view the full-text HTML version.

For subscription articles, only subscribers will be able to download, print and save an enhanced PDF, or to view the full-text HTML version.

Authors can request shareable links of other research articles that they have authored with most Springer Nature journals by entering the article’s DOI into our author portal

Springer Nature has a sample social media plan to help authors promote their research via Facebook and Twitter. The four-week campaign utilizes the SharedItlink to gain visibility through concentrated daily marketing, using both direct and indirect (post comments) methods.

For more Information please visit the SharedIt page on Springernature.com.

APASL Guidelines

The Guideline written by Dr. T Kanda has been published!

APASL Guidelines for HCC -”Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update” (Hepatol Int 2017; 11: 317-370)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for HCC (Hepatol Int 2017; 11: 317-370)

APASL Guidelines for HBV -“Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update” (Hepatol Int 2016; 10:1–98)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for HBV (Hepatol Int 2016; 10:1–98)

APASL Guidelines for HCV -”APASL consensus statements and recommendation for hepatitis C prevention, epidemiology, and laboratory testing” (Hepatol Int 2016 10:681–701)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for HCV (Hepatol Int 2016 10:681–701)

APASL Guidelines for HCV -”APASL consensus statements and recommendation on treatment of hepatitis C” (Hepatol Int 2016 10:702–726)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for HCV (Hepatol Int 2016 10:702–726)

APASL Guidelines for Acute-on-chronic Liver Failure -”Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014” (Hepatol Int 2014; 8: 453-471)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for Acute-on-chronic Liver Failure (Hepatol Int 2014; 8: 453-471)

APASL Guidelines for Fibrosis -”Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)” (Hepatol Int 2009; 3: 323-333)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for Fibrosis (Hepatol Int 2009; 3: 323-333)

APASL consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis a 2016 update (Hepatol Int 2017 11:1–30)

*This APASL Guideline can be downloaded by clicking below.

Consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update (Hepatol Int 2017 11:1–30)

APASL Guidelines for IPH -”Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment” (Hepatol Int 2007; 1: 398-413)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for IPH

APASL Guidelines for Variceal Bleeding -”Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver” (Hepatol Int 2008; 2: 429-439)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for Variceal Bleeding
Our Journal is Now on Medline! And available to all APASL members!!

Dear APASL member
It is a matter of great satisfaction and joy to inform that the Hepatology International has been recently accepted by Medline for indexing, and all the papers published so far are now cited on PubMed. This has been a long standing requirement of the APASL members and the academic community of this journal, which has been fulfilled now.
Please log into the member site of APASL https://www.apasl.info/membership/member/ with your ID and Password, and reach the journal content through the hyperlink.

APASL Guidelines

Now the following APASL Guidelines have been published in Hepatology International !!!

APASL Guidelines for HBV (Hepatol Int 2016; 10: 1-98)
APASL Guidelines for HCV (Hepatol Int 2016; 10: 681-726)
APASL Guidelines for HCC (Hepatol Int 2017; 11: 317-370)
APASL Guidelines for ACLF (Hepatol Int 2014; 8: 453 – 471)
APASL Guidelines for Fibrosis (Hepatol Int 2009; 3: 323-333)
APASL Consensus Guidelines on Invasive and Non-Invasive Assessment of Hepatic Fibrosis a 2016 update (Hepatol Int 2017 11:1–30)
APASL Guidelines for IPH (Hepatol Int 2007; 1: 398-413)
APASL Guidelines for Variceal Bleeding (Hepatol Int 2008; 2: 429-439)